LONDON, Nov 7 — Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

The company's semaglutide injection—better known by the brand names Ozempic and Wegovy—has become well-known for its weight-loss results and ability to manage diabetes. And while there are several ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

Shares in Novo Nordisk which competes with Eli Lilly in an obesity drug market that some analysts forecast could be worth about $150 billion by the early 2030s, rose nearly 9%.

Semaglutide has been on the FDA's shortage list since 2022, which has enabled compounding pharmacies and manufactures to make their own, unapproved versions of the drug. Novo Nordisk in October ...

Judicial appointments and more - A Trump administration could also seek to undo the stringent patient privacy protections put ...

WASHINGTON: Donald Trump has already appointed three Supreme Court justices. In his second term, he could well have a chance to name two more, creating a high court with a Trump-appointed majority ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...

Israel State Auditor Holds Tax Authority Accountable for $800M Crypto Tax Gap: Report ...

Archaeologists working at Tel Shimron in northern Israel have uncovered an enormous ancient structure filled with Canaanite cultic artifacts. This remarkable collection includes objects likely used in ...